StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie operating Lease Weighted-Average Discount Rate (%) (%)

Form 10-K Leases Note

Latest, FY2025
3.5%
Period ended Dec 31, 2025
Change on a year earlier
+0.2 pts
3.3% in FY2024
History
7 years
Since FY2019
Sources
5
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOperating Lease Weighted-Average Discount Rate (%) (%)Year on yearSource
FY2025Dec 31, 20253.5%+0.2 ptsForm 10-K (filed 2026-02-20) ↗
FY2024Dec 31, 20243.3%+0.3 ptsForm 10-K (filed 2026-02-20) ↗
FY2023Dec 31, 20233.0%+0.4 ptsForm 10-K (filed 2026-02-20) ↗
FY2022Dec 31, 20222.6%+0.2 ptsForm 10-K (filed 2025-02-14) ↗
FY2021Dec 31, 20212.4%-0.1 ptsForm 10-K (filed 2024-02-20) ↗
FY2020Dec 31, 20202.5%-1.4 ptsForm 10-K (filed 2023-02-17) ↗
FY2019Dec 31, 20193.9%–Form 10-K (filed 2022-02-18) ↗

Cite this data

StockData. (2026). AbbVie Operating Lease Weighted-Average Discount Rate (%) (%), annual FY2019–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/op_lease_disc

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.